ACTC1 Antibody, anti-human, Vio® B515, REAdye_lease™, 200 µL
文献支持

ACTC1 Antibody, anti-human, Vi

o® B515, REAdye_lease™, 200 µL
收藏
  • 询价
  • Miltenyi Biotec已认证
  • 德国
  • 130-133-121
  • 2025年12月09日
  • MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry
  • cell line
  • human
avatar
品牌商
13钻石会员
  • 企业认证

    • 详细信息
    • 文献和实验
    • 技术资料
    • 免疫原

      ACTC1

    • 形态

      Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.

    • 保存条件

      避光,4-8℃

    • 克隆性

      REAL1174

    • 标记物

      Vio B515

    • 适应物种

      human

    • 保质期

      24个月

    • 供应商

      Miltenyi biotec

    • 宿主

      cell line

    • 应用范围

      MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry

    • 抗体英文名

      ACTC1 Antibody, anti-human, REAdye_lease™

    • 抗体名

      ACTC1 Antibody, anti-human, REAdye_lease™

    • 规格

      200 µL

    Detection of ACTC1+ cellsClone REAL1174 is an antibody fragment derived from the full ACTC1 antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAdye_lease Complex to bind markers with high avidity. | Clone REAL1174 recognizes ACTC1, which is also known as cardiac muscle alpha actin or Alpha-cardiac actin. It is an important protein of the thin filament in cardiac sarcomeres, which play a crucial role in muscle contraction and support the pump function of the heart. It belongs to the actin family, highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in eukaryotic cells. Mutations in ACTC1 lead to dilated cardiomyopathy. ACTC1 is considered as a prognostic marker for glioma and for liver metastasis. | For removal of REAdye_lease fluorochromes for optional relabeling with different fluorochrome-conjugated REAdye_lease antibodies use the REAlease Support Kit (130-120-675). |

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    Olson, T. M. et al. (1998) Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 280 (5364): 750–752. | Ohtaki, S. et al. (2017) ACTC1 as an invasion and prognosis marker in glioma. J Neurosurg. 126 (2): 467–475. | Eun-Kyung, K. et al. (2019) Proteomic Analysis of Primary Colon Cancer and Synchronous Solitary Liver Metastasi. Cancer Genomics Proteomics 16 (6): 583–592. | Ingles, J. et al. (2019) Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes. Circ Genom Precis Med 12 (2): e002460..
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    德国美天旎生物技术有限公司
    2025年12月09日询价
    询价
    上海联迈生物工程有限公司
    2025年03月19日询价
    询价
    普健生物(武汉)科技有限公司
    2025年12月19日询价
    文献支持
    ACTC1 Antibody, anti-human, Vio® B515, REAdye_lease™, 200 µL
    询价